Interplay between steroid receptors and neoplastic progression in sarcoma tumors

Journal of Cellular Physiology

Volumn 226, Issue 11, 2011, Pages 2997-3003

  Fiorelli, A ^a   Ricciardi, C ^a   Pannone, G ^b   Santoro, A ^b   Bufo, P ^b   Santini, M ^a   Serpico, R ^a   Rullo, R ^a   Pierantoni, G M ^c,d   di Domenico, M ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CORTICOSTEROID ANTAGONIST; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL RECEPTOR; GELATINASE B; STEROID RECEPTOR; TYROSINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER LOCALIZATION; CELL STRAIN MCF 7; CHILD; CLINICAL ARTICLE; DISEASE COURSE; ELECTROPHORESIS; FEMALE; FIBROSARCOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; LEIOMYOSARCOMA; LIPOSARCOMA; MALE; METASTASIS; MYXOSARCOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SCHOOL CHILD; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAIN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; ESTRADIOL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; MALE; METRIBOLONE; MIDDLE AGED; PILOT PROJECTS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, STEROID; SARCOMA; SIGNAL TRANSDUCTION; SOFT TISSUE NEOPLASMS; SRC-FAMILY KINASES; YOUNG ADULT;

EID: 79959725100     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22645     Document Type: Article

References (34)

1. Beech D, Pollock RE, Tsan R, Radinsky R. 1998. Epidermal growth factor receptor and insulin-like growth factor-I receptor expression and function in human soft-tissue sarcoma cells. Int J Oncol 12: 329-336.
2. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D. 2000. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2: 737-744.
3. Castoria G, Migliaccio A, Green S, Di Domenico M, Chambon P, Auricchio F. 1993. Properties of a purified estradiol-dependent calf uterus tyrosine kinase. Biochemistry 32: 1740-1750.
4. Castoria G, Migliaccio A, Bilancio A, Di Domenico M, De Falco A, Lombardi M, Fiorentino R, Varricchio L, Barone MV, Auricchio F. 2001. PI3-kinase in concert with Src promotes the S-phase entry of estradiol-stimulated MCF-7 cells. EMBO J 20: 6050-6059.
5. Castoria G, Lombardi M, Barone MV, Bilancio A, Di Domenico M, Bottero D, Vitale F, Migliaccio A, Auricchio F. 2003. Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a non transcriptional receptor action. J Cell Biol 161: 547-556.
6. Castoria G, Migliaccio A, Di Domenico M, Lombardi M, De Falco A, Varricchio L, Bilancio A, Barone MV, Auricchio F. 2004. Role of atypical PKC in estradiol-triggered G1/S progression of MCF-7 cells. Mol Cell Biol 24: 7643-7653.
7. De Giovanni C, Landuzzi L, Frabetti F, Nicoletti G, Griffoni C, Rossi I, Mazzotti M, Scotto L, Nanni P, Lollini PL. 1996. Antisense epidermal growth factor receptor transfection impairs the proliferative ability of human rhabdomyosarcoma cells. Cancer Res 56: 3898-3901.
8. Di Domenico M, Castoria G, Bilancio A, Migliaccio A, Auricchio F. 1996. Estradiol activation of human colon carcinoma-derived Caco-2 cell growth. Cancer Res 56: 4516-4521.
9. Gusterson B, Cowley G, Mcllhinnery J, Ozanne B, Fisher C, Reeves B. 1985. Evidence of increased epidermal growth factor receptors in human sarcomas. Int J Cancer 36: 689-693.
10. Hewitt C, Harrell JC, Korach KS. 2005. Lessons in estrogen biology from knockout and transgenic animals. Annu Rev Physiol 67: 285-308.
11. Hsu SM, Raine L, Fanger H. 1981. Use of avidin-biotin-peroxidase complex (ABC) immunoperoxidase techniques: A comparison between ABC and unlabelled antibody (PAP) procedures. Histochem Cytochem 29: 577-580.
12. Ignar-Trowbridge DM, Nelson KG, Bidwell MC, Curtis SW, Washburn TF, McLachlan JA, Korach KS. 1992. Coupling of dual signaling pathways: Epidermal growth factor action involves the estrogen receptor. Proc Natl Acad Sci USA 89: 4658-4662.
13. Jarrousse F, Boisnic S, Branchet MC, Beranger JY, Godeau G, Breton L, Bernard BA, Mahé YF. 2001. Identification of clustered cells in human hair follicle responsible for MMP-9 gelatinolytic activity: Consequences for the regulation of hair growth. Int J Dermatol 40: 385-392.
14. Kwak HJ, Park MJ, Cho H, Park CM, Moon SI, Lee HC, Park IC, Kim MS, Rhee CH, Hong SI. 2006. Transforming growth factor-β1 induces tissue inhibitor of metalloproteinase-1 expression via activation of extracellular signal regulated kinase and Sp1 in human fibrosarcoma cells. Mol Cancer Res 4: 209-220.
15. Lo HW, Hsu SC, Ali-Seyed M, Gunduz M, Xia W, Wei Y, Bartholomeusz G, Shih JY, Hung MC. 2005. Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. Cancer Cell 7: 575-589.
16. McCawley LJ, Matrisian LM. 2001. Matrix metalloproteinases: They're not just for matrix anymore. Curr Opin Cell Biol 13: 534-540.
17. Migliaccio A, Di Domenico M, Castoria G, De Falco A, Bontempo P, Nola E, Auricchio F. 1996. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 15: 1292-1300.
18. ras /erk pathway by progesterone receptor via a crosstalk with estrogen receptor. EMBO J 17: 2008-2018.
19. Migliaccio A, Castoria G, Di Domenico M, De Falco A, Bilancio A, Lombardi M, Barone MV, Ametrano D, Zannini MS, Abbondanza C, Auricchio F. 2000. Steroid-induced androgen receptor-oestradiol receptor-beta Src complex triggers prostate cancer cell proliferation. EMBO J 19: 5406-5417.
20. Migliaccio A, Di Domenico M, Castoria G, Nanayakkara M, Lombardi M, De Falco A, Bilancio A, Varricchio L, Ciociola A, Auricchio F. 2005. Steroid receptor regulation of EGF signaling through Src in breast and prostate cancer cells: Steroid antagonist action. Cancer Res 65: 10585-10593.
21. Migliaccio A, Castoria G, Di Domenico M, Ciociola A, Lombardi M, De Falco A, Nanayakkara M, Bottero D, De Stasio R, Varricchio L, Auricchio F. 2006. Crosstalk between EGFR and extranuclear steroid receptors. Acad Sci 1089: 194-200.
22. Nair RR, Julian S, Douglas DB. 2006. Expression cloning identifies transgelin (SM22) as a novel repressor of 92-kDa type IV collagenase (MMP-9) expression. J Biol Chem 281: 26424-26436.
23. Nielsen TO, Hsu FD, O'Connell JX, Gilks CB, Sorensen PH, Linn S, West RB, Liu CL, Botstein D, Brown PO, Van de Rijn M. 2003. Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology. Am J Pathol 163: 1449-1456.
24. Noël A, Jost M, Maquoi E. 2008. Matrix metalloproteinases at cancer tumor-host interface. Cell Dev Biol 19: 52-60.
25. O'Malley BW. 2005. A life-long search for the molecular pathways of steroid hormone action. Mol Endocrinol 19: 1402-1411.
26. Perosio PM, Brooks JJ. 1989. Expression of growth factors and growth factor receptors in soft tissue tumors. Implications for the autocrine hypothesis. Lab Invest 60: 245-253.
27. Razandi M, Pedram A, Park ST, Levin ER. 2003. Proximal events in signaling by plasma membrane estrogen receptors. J Biol Chem 278: 2701-2712.
28. Ren W, Korchin B, Zhu QS, Wei C, Dicker A, Heymach J, Lazar A, Pollock RE, Lev D. 2008. Epidermal growth factor receptor blockade in combination with conventional chemotherapy inhibits soft tissue sarcoma cell growth in vitro and in vivo. Clin Cancer Res 14: 2785-2795.
29. Salvatori L, Caporuscio F, Coroniti G, Starace G, Frati L, Russo MA, Petrangeli E. 2009. Down-regulation of epidermal growth factor receptor induced by estrogens and phytoestrogens promotes the differentiation of U2OS human osteosarcoma cells. J Cell Physiol 220: 35-44.
30. Sato O, Wada T, Kawai A, Yamaguchi U, Makimoto A, Kokai Y, Yamashita T, Chuman H, Beppu Y, Tani Y, Hasegawa T. 2005. Expression of epidermal growth factor receptor, ERBB2 and KIT in adult soft tissue sarcomas: A clinicopathologic study of 281 cases. Cancer 103: 1881-1890.
31. Sivak JM, Fini ME. 2002. MMPs in the eye: Emerging roles for matrix metalloproteinases in ocular physiology. Prog Retin Eye Res 21: 1-14.
32. Tanaka K, Iwamoto Y, Ito Y, Ishibashi T, Nakabeppu Y, Sekiguchi M, Sugioka Y. 1995. Cyclic AMP-regulated synthesis of the tissue inhibitors of metalloproteinases suppresses the invasive potential of the human fibrosarcoma cell line HT1080. Cancer Res 55: 2927-2935.
33. Vignon F, Bouton MM, Rochefort H. 1987. Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens. Biochem Biophys Res Commun 146: 1502-1508.
34. Zhuge Y, Xu J. 2001. Rac1 mediates type I collagen-dependent MMP-2 activation. J Biol Chem 276: 16248-16256.